
Opinion|Videos|February 26, 2024
NCCN Guidelines: Implementing New Therapy Options for Ovarian Cancer
Ronald D. Alvarez, MD, MBA, discusses challenges in implementing updated NCCN guidelines, such as coverage limitations imposed by payers.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata
2
First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA
3
Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story
4
5 Notable Oncology FDA Approvals Granted in May
5






